Trappsol Cyclo

Hydroxypropyl-β-cyclodextrin · Cyclo Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Trappsol Cyclo, covering 2021-08-10 to 2024-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1 [Phase 3]

See pricing